Anti-FKBP9/ FKBP60/ FKBP63 functional antibody

Anti-FKBP9/ FKBP60/ FKBP63 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to FKBP9/FKBP9 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0221-Ab-1/ GM-Tg-hg-SE0221-Ab-2Anti-Human FKBP9 monoclonal antibodyHuman
GM-Tg-rg-SE0221-Ab-1/ GM-Tg-rg-SE0221-Ab-2Anti-Rat FKBP9 monoclonal antibodyRat
GM-Tg-mg-SE0221-Ab-1/ GM-Tg-mg-SE0221-Ab-2Anti-Mouse FKBP9 monoclonal antibodyMouse
GM-Tg-cynog-SE0221-Ab-1/ GM-Tg-cynog-SE0221-Ab-2Anti-Cynomolgus/ Rhesus macaque FKBP9 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0221-Ab-1/ GM-Tg-felg-SE0221-Ab-2Anti-Feline FKBP9 monoclonal antibodyFeline
GM-Tg-cang-SE0221-Ab-1/ GM-Tg-cang-SE0221-Ab-2Anti-Canine FKBP9 monoclonal antibodyCanine
GM-Tg-bovg-SE0221-Ab-1/ GM-Tg-bovg-SE0221-Ab-2Anti-Bovine FKBP9 monoclonal antibodyBovine
GM-Tg-equg-SE0221-Ab-1/ GM-Tg-equg-SE0221-Ab-2Anti-Equine FKBP9 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0221-Ab-1/ GM-Tg-hg-SE0221-Ab-2; GM-Tg-rg-SE0221-Ab-1/ GM-Tg-rg-SE0221-Ab-2;
GM-Tg-mg-SE0221-Ab-1/ GM-Tg-mg-SE0221-Ab-2; GM-Tg-cynog-SE0221-Ab-1/ GM-Tg-cynog-SE0221-Ab-2;
GM-Tg-felg-SE0221-Ab-1/ GM-Tg-felg-SE0221-Ab-2; GM-Tg-cang-SE0221-Ab-1/ GM-Tg-cang-SE0221-Ab-2;
GM-Tg-bovg-SE0221-Ab-1/ GM-Tg-bovg-SE0221-Ab-2; GM-Tg-equg-SE0221-Ab-1/ GM-Tg-equg-SE0221-Ab-2
Products NameAnti-FKBP9 monoclonal antibody
Formatmab
Target NameFKBP9
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-FKBP9 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0221-Ag-1Recombinant multi-species FKBP9/ FKBP60/ FKBP63 protein
    ORF Viral VectorpGMLPm002674mouse Fkbp9 Lentivirus plasmid
    ORF Viral VectorvGMLPm002674mouse Fkbp9 Lentivirus particle


    Target information

    Target IDGM-SE0221
    Target NameFKBP9
    Gene ID11328,27055,297123,708827,475276,101091007,534182,100070168
    Gene Symbol and Synonyms1810014L23,FKBP-63,FKBP-9,FKBP60,FKBP63,FKBP65RS,FKBP9,PPIase
    Uniprot AccessionO95302,Q66H94,Q2KJC8
    Uniprot Entry NameFKBP9_HUMAN,FKBP9_RAT,FKBP9_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000122642
    Target ClassificationN/A

    The target: FKBP9, gene name: FKBP9, also named as FKBP60, FKBP63, PPIase. Predicted to enable calcium ion binding activity. Predicted to be involved in protein folding. Predicted to be located in endoplasmic reticulum. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.